Review



smfish staining bioptechs fcs2 fcs2 stage adapter bioptechs  (Bioptechs inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Bioptechs inc smfish staining bioptechs fcs2 fcs2 stage adapter bioptechs
    Smfish Staining Bioptechs Fcs2 Fcs2 Stage Adapter Bioptechs, supplied by Bioptechs inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bioptechs+fcs2/pm41990751-296-170-172?v=Bioptechs+inc
    Average 96 stars, based on 1 article reviews
    smfish staining bioptechs fcs2 fcs2 stage adapter bioptechs - by Bioz Stars, 2026-08
    96/100 stars

    Images



    Similar Products

    96
    Bioptechs inc smfish staining bioptechs fcs2 fcs2 stage adapter bioptechs
    Smfish Staining Bioptechs Fcs2 Fcs2 Stage Adapter Bioptechs, supplied by Bioptechs inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bioptechs+fcs2/pm41990751-296-170-172?v=Bioptechs+inc
    Average 96 stars, based on 1 article reviews
    smfish staining bioptechs fcs2 fcs2 stage adapter bioptechs - by Bioz Stars, 2026-08
    96/100 stars
      Buy from Supplier

    96
    Bioptechs inc bioptechs fcs2
    Bioptechs Fcs2, supplied by Bioptechs inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bioptechs+fcs2/bio_rxiv__64898__2026__03__27__714828-316-5-5?v=Bioptechs+inc
    Average 96 stars, based on 1 article reviews
    bioptechs fcs2 - by Bioz Stars, 2026-08
    96/100 stars
      Buy from Supplier

    96
    Bioptechs inc fcs2 chamber bioptechs inc n
    Fcs2 Chamber Bioptechs Inc N, supplied by Bioptechs inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bioptechs+fcs2/pm41813847-268-81-83?v=Bioptechs+inc
    Average 96 stars, based on 1 article reviews
    fcs2 chamber bioptechs inc n - by Bioz Stars, 2026-08
    96/100 stars
      Buy from Supplier

    96
    Bioptechs inc bioptechs fcs2 chamber
    A) Schematic of generating rifampin-induced persisters and evaluating persister survival rates. B) Survival rate (mean value ± standard deviation) of E. coli MG1655 cells against ampicillin with no pretreatment ( A ) and rifampin-pretreatment ( R-A ). Data represent results from six independent experiments. C) Motile percentage (mean value ± standard deviation) of mid-exponential phase cells ( M ), rifampin-treated cells ( R ), rifampin-induced persisters ( R-A ). Data represent results from five experimental videos. The total numbers of cells in the five videos are 598 ( M ), 663 ( R ), and 291 ( R-A ), respectively. D - F) Representative trajectories of mid-exponential phase cells ( D ), rifampin-treated cells ( E ), and persisters ( F ) swimming in their original living environment (LB or LB with corresponding antibiotics), imaged in the <t>FCS2</t> chamber. The colored lines show the trajectories of different cells. G , H) Comparison of track mean speed ( G ) and track mean directional change rate ( H ) distributions for mid-exponential phase cells ( M ), rifampin-treated cells ( R ), and persisters ( R-A ). Data were obtained from at least three experimental videos. Sample sizes for mid-exponential phase cell, rifampin-treated cell, and persister are 6358, 6580, and 4610 tracks, respectively.
    Bioptechs Fcs2 Chamber, supplied by Bioptechs inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bioptechs+fcs2/bio_rxiv__64898__2025__12__17__694804-52-23-23?v=Bioptechs+inc
    Average 96 stars, based on 1 article reviews
    bioptechs fcs2 chamber - by Bioz Stars, 2026-08
    96/100 stars
      Buy from Supplier

    96
    Bioptechs inc bioptechs fcs2 flow chamber
    A) Schematic of generating rifampin-induced persisters and evaluating persister survival rates. B) Survival rate (mean value ± standard deviation) of E. coli MG1655 cells against ampicillin with no pretreatment ( A ) and rifampin-pretreatment ( R-A ). Data represent results from six independent experiments. C) Motile percentage (mean value ± standard deviation) of mid-exponential phase cells ( M ), rifampin-treated cells ( R ), rifampin-induced persisters ( R-A ). Data represent results from five experimental videos. The total numbers of cells in the five videos are 598 ( M ), 663 ( R ), and 291 ( R-A ), respectively. D - F) Representative trajectories of mid-exponential phase cells ( D ), rifampin-treated cells ( E ), and persisters ( F ) swimming in their original living environment (LB or LB with corresponding antibiotics), imaged in the <t>FCS2</t> chamber. The colored lines show the trajectories of different cells. G , H) Comparison of track mean speed ( G ) and track mean directional change rate ( H ) distributions for mid-exponential phase cells ( M ), rifampin-treated cells ( R ), and persisters ( R-A ). Data were obtained from at least three experimental videos. Sample sizes for mid-exponential phase cell, rifampin-treated cell, and persister are 6358, 6580, and 4610 tracks, respectively.
    Bioptechs Fcs2 Flow Chamber, supplied by Bioptechs inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bioptechs+fcs2/pm41283390-111-33-33?v=Bioptechs+inc
    Average 96 stars, based on 1 article reviews
    bioptechs fcs2 flow chamber - by Bioz Stars, 2026-08
    96/100 stars
      Buy from Supplier

    Image Search Results


    A) Schematic of generating rifampin-induced persisters and evaluating persister survival rates. B) Survival rate (mean value ± standard deviation) of E. coli MG1655 cells against ampicillin with no pretreatment ( A ) and rifampin-pretreatment ( R-A ). Data represent results from six independent experiments. C) Motile percentage (mean value ± standard deviation) of mid-exponential phase cells ( M ), rifampin-treated cells ( R ), rifampin-induced persisters ( R-A ). Data represent results from five experimental videos. The total numbers of cells in the five videos are 598 ( M ), 663 ( R ), and 291 ( R-A ), respectively. D - F) Representative trajectories of mid-exponential phase cells ( D ), rifampin-treated cells ( E ), and persisters ( F ) swimming in their original living environment (LB or LB with corresponding antibiotics), imaged in the FCS2 chamber. The colored lines show the trajectories of different cells. G , H) Comparison of track mean speed ( G ) and track mean directional change rate ( H ) distributions for mid-exponential phase cells ( M ), rifampin-treated cells ( R ), and persisters ( R-A ). Data were obtained from at least three experimental videos. Sample sizes for mid-exponential phase cell, rifampin-treated cell, and persister are 6358, 6580, and 4610 tracks, respectively.

    Journal: bioRxiv

    Article Title: Motility Functions as an Essential Defense in the Bacterial Persister Lifecycle

    doi: 10.64898/2025.12.17.694804

    Figure Lengend Snippet: A) Schematic of generating rifampin-induced persisters and evaluating persister survival rates. B) Survival rate (mean value ± standard deviation) of E. coli MG1655 cells against ampicillin with no pretreatment ( A ) and rifampin-pretreatment ( R-A ). Data represent results from six independent experiments. C) Motile percentage (mean value ± standard deviation) of mid-exponential phase cells ( M ), rifampin-treated cells ( R ), rifampin-induced persisters ( R-A ). Data represent results from five experimental videos. The total numbers of cells in the five videos are 598 ( M ), 663 ( R ), and 291 ( R-A ), respectively. D - F) Representative trajectories of mid-exponential phase cells ( D ), rifampin-treated cells ( E ), and persisters ( F ) swimming in their original living environment (LB or LB with corresponding antibiotics), imaged in the FCS2 chamber. The colored lines show the trajectories of different cells. G , H) Comparison of track mean speed ( G ) and track mean directional change rate ( H ) distributions for mid-exponential phase cells ( M ), rifampin-treated cells ( R ), and persisters ( R-A ). Data were obtained from at least three experimental videos. Sample sizes for mid-exponential phase cell, rifampin-treated cell, and persister are 6358, 6580, and 4610 tracks, respectively.

    Article Snippet: To capture the natural swimming behavior of cells in their original living environment, we directly placed 8 μL of bacterial culture onto the Bioptechs FCS2 chamber (0.2 mm plastic pad between slide and coverslip) and used a Nikon ECLIPSE Ti inverted microscope to record bright-field videos at approximately 22 frames per second (FPS).

    Techniques: Standard Deviation, Comparison

    A) Representative trajectories of mid-exponential phase cells swimming in LB after CCCP exposure, observed in the FCS2 chamber. The colored lines show the trajectories of different cells. B) Survival rate (mean value ± standard deviation) of E. coli cells against ampicillin with exposure to CCCP before rifampin ( C-R-A ), exposure to CCCP and rifampin together ( CR-A ), exposure to CCCP and ampicillin together after rifampin ( R-CA ), and 15% w/v Ficoll in culture medium upon rifampin exposure ( 15%FR-A ). Data represent results from six independent experiments. C) Membrane potential (mean value ± standard deviation) of mid-exponential phase cells treated with CCCP ( CCCP ), experiencing no treatment ( M ), treated with 5% ( 5%F ), 10% ( 10%F ), and 15% ( 15%F ) w/v Ficoll, as indicated by the red/green median fluorescence intensity ratio measured by flow cytometry. Data represent results from at least three independent experiments. D) Representative trajectories of mid-exponential phase cells swimming in LB with 15% w/v Ficoll, imaged in the FCS2 chamber. The colored lines show the trajectories of different cells. E) Two-dimensional distribution correlating track mean speed and track mean directional change rate for mid-exponential phase cells in LB with 15% w/v Ficoll, with corresponding marginal distributions. The sample size is 5374 tracks, obtained from seven videos. F) Relationship between rifampin-induced survival rate against ampicillin (mean) and swimming speed (mean) for cells under different conditions: M , 15%F , and CCCP .

    Journal: bioRxiv

    Article Title: Motility Functions as an Essential Defense in the Bacterial Persister Lifecycle

    doi: 10.64898/2025.12.17.694804

    Figure Lengend Snippet: A) Representative trajectories of mid-exponential phase cells swimming in LB after CCCP exposure, observed in the FCS2 chamber. The colored lines show the trajectories of different cells. B) Survival rate (mean value ± standard deviation) of E. coli cells against ampicillin with exposure to CCCP before rifampin ( C-R-A ), exposure to CCCP and rifampin together ( CR-A ), exposure to CCCP and ampicillin together after rifampin ( R-CA ), and 15% w/v Ficoll in culture medium upon rifampin exposure ( 15%FR-A ). Data represent results from six independent experiments. C) Membrane potential (mean value ± standard deviation) of mid-exponential phase cells treated with CCCP ( CCCP ), experiencing no treatment ( M ), treated with 5% ( 5%F ), 10% ( 10%F ), and 15% ( 15%F ) w/v Ficoll, as indicated by the red/green median fluorescence intensity ratio measured by flow cytometry. Data represent results from at least three independent experiments. D) Representative trajectories of mid-exponential phase cells swimming in LB with 15% w/v Ficoll, imaged in the FCS2 chamber. The colored lines show the trajectories of different cells. E) Two-dimensional distribution correlating track mean speed and track mean directional change rate for mid-exponential phase cells in LB with 15% w/v Ficoll, with corresponding marginal distributions. The sample size is 5374 tracks, obtained from seven videos. F) Relationship between rifampin-induced survival rate against ampicillin (mean) and swimming speed (mean) for cells under different conditions: M , 15%F , and CCCP .

    Article Snippet: To capture the natural swimming behavior of cells in their original living environment, we directly placed 8 μL of bacterial culture onto the Bioptechs FCS2 chamber (0.2 mm plastic pad between slide and coverslip) and used a Nikon ECLIPSE Ti inverted microscope to record bright-field videos at approximately 22 frames per second (FPS).

    Techniques: Standard Deviation, Membrane, Fluorescence, Flow Cytometry